Skip to main content

Intuitive Surgical Inc

ISRG
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001035267

In the last 90 days, Intuitive Surgical Inc insiders filed 0 open-market purchases and 14 sales; 2,273 institutions reported holding it in 13F filings for Q2 2026, worth $122.0B in total; 3 superinvestors hold it, including Coatue Management and D1 Capital Partners.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 22, 2026, 1:07 AM ET

Revenue flow, FY2025

Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Income statement

Each column is one fiscal year, newest first.

Income statement of Intuitive Surgical Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
ReportedJan 14, 2026Jan 15, 2025Jan 9, 2024Jan 11, 2023Jan 12, 2022
Revenue$10.1B$8.35B$7.12B$6.22B$5.71B
Cost of revenue$3.42B$2.72B$2.39B$2.03B$1.75B
Gross profit$6.64B$5.63B$4.73B$4.20B$3.96B
Operating expenses$3.70B$3.29B$2.96B$2.62B$2.14B
Research and development$1.31B$1.15B$998.8M$879.0M$671.0M
Selling, general and administrative$2.38B$2.14B$1.96B$1.74B$1.47B
Operating income$2.95B$2.35B$1.77B$1.58B$1.82B
Income tax$434.8M$336.3M$141.6M$262.4M$162.2M
Net income$2.86B$2.32B$1.80B$1.32B$1.70B
EPS, basic$8.00$6.54$5.12$3.72$4.79
EPS, diluted$7.87$6.42$5.03$3.65$4.66
Weighted shares, basic356.9M355.2M351.2M355.7M356.1M
Weighted shares, diluted362.7M362.0M357.4M362.0M365.8M
Margins and growth
Gross margin66.0%67.5%66.4%67.4%69.3%
Operating margin29.3%28.1%24.8%25.3%31.9%
Net margin28.4%27.8%25.2%21.3%29.9%
Revenue growth, year over year+20.5%+17.2%+14.5%+9.0%+31.0%
Net income growth, year over year+23.0%+29.2%+36.0%−22.4%+60.7%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Intuitive Surgical Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
ReportedJan 14, 2026Jan 15, 2025Jan 9, 2024Jan 11, 2023Jan 12, 2022
Cash and equivalents$3.37B$2.03B$2.75B$1.58B$1.29B
Short-term investments$2.57B$1.99B$2.47B$2.54B$2.91B
Accounts receivable$1.53B$1.23B$1.13B$942.1M$782.7M
Inventory$1.84B$1.49B$1.22B$893.2M$587.1M
Total current assets$9.78B$7.11B$7.89B$6.25B$5.84B
Property, plant and equipment$5.34B$4.65B$3.54B$2.37B$1.88B
Goodwill$370.3M$347.5M$348.7M$348.5M$343.6M
Intangible assets$17.1M$23.0M$39.1M$49.8M$70.5M
Total assets$20.5B$18.7B$15.4B$13.0B$13.6B
Accounts payable$255.1M$193.4M$188.7M$147.0M$121.2M
Total current liabilities$2.01B$1.75B$1.66B$1.42B$1.15B
Total liabilities$2.52B$2.21B$2.04B$1.86B$1.60B
Shareholders' equity$17.9B$16.5B$13.4B$11.1B$12.0B

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Intuitive Surgical Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
ReportedJan 14, 2026Jan 15, 2025Jan 9, 2024Jan 11, 2023Jan 12, 2022
Operating cash flow$3.03B$2.42B$1.81B$1.49B$2.09B
Capital expenditures$539.8M$1.11B$1.06B$532.4M$353.5M
Free cash flow$2.49B$1.30B$749.6M$958.4M$1.74B
Stock-based compensation$788.2M$676.8M$592.8M$513.2M$449.2M
Share buybacks$2.30B$0$416.3M$2.61B$0
Investing cash flow$665.8M-$3.27B-$360.1M$1.37B-$2.46B
Financing cash flow-$2.36B$150.9M-$287.6M-$2.57B$43.0M
Net change in cash$1.34B-$707.7M$1.17B$294.7M-$332.5M
Ratio
Stock-based compensation, % of revenue7.8%8.1%8.3%8.2%7.9%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Intuitive Surgical Inc by cover date
Cover dateShares outstandingChange in a yearFiling
Oct 15, 2026346.6M−2.2%SEC
Jul 16, 2026353.3M−1.5%SEC
Apr 15, 2026354.2M−1.2%SEC
Jan 28, 2026355.1M−0.4%SEC
Oct 16, 2025354.5M−0.5%SEC
Jul 17, 2025358.5M+0.9%SEC
Apr 15, 2025358.4M+1.0%SEC
Jan 27, 2025356.7M+1.2%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Dec 31, 2020, from 13F share counts: 3-for-1 in Q4 2021.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.